Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 2/20 | 0.57 |
| ▸ | MEN1 | O00255 | 4/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.46 |
| ▸ | CREBBP | Q92793 | 2/20 | 0.46 |
| ▸ | BRD4 | O60885 | 1/20 | 0.46 |
| ▸ | RAB9A | P51151 | 2/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.39 |
| ▸ | MAPT | P10636 | 2/20 | 0.39 |
| ▸ | POLB | P06746 | 2/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.39 |
| ▸ | GAA | P10253 | 2/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | BCHE | P06276 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.39 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.39 |
| ▸ | MAOA | P21397 | 1/20 | 0.39 |
| ▸ | CNR1 | P21554 | 1/20 | 0.39 |
| ▸ | ACHE | P22303 | 1/20 | 0.39 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16181708 | 1.00 | IDO1 (0.57) | IDO1MEN1KMT2ACREBBPBRD4 | |
| SCHEMBL12661831 | 1.00 | IDO1 (0.57) | IDO1MEN1KMT2ACREBBPBRD4 | |
| SCHEMBL16711400 | 1.00 | IDO1 (0.57) | IDO1MEN1KMT2ACREBBPBRD4 | |
| SCHEMBL21808704 | 0.76 | IDO1 (0.61) | IDO1MEN1KMT2ACREBBPBRD4 | |
| SCHEMBL19621659 | 0.74 | IDO1 (0.49) | IDO1MEN1KMT2ACREBBPBRD4 | |
| SCHEMBL6185177 | 0.73 | IDO1 (0.57) | IDO1MEN1KMT2ACREBBPBRD4 | |
| SCHEMBL11502327 | 0.73 | IDO1 (0.57) | IDO1MEN1KMT2ACREBBPBRD4 | |
| SCHEMBL11118464 | 0.73 | IDO1 (0.57) | IDO1MEN1KMT2ACREBBPBRD4 | |
| SCHEMBL1754221 | 0.73 | IDO1 (0.57) | IDO1MEN1KMT2ACREBBPBRD4 | |
| SCHEMBL11539110 | 0.73 | IDO1 (0.57) | IDO1MEN1KMT2ACREBBPBRD4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 57 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4845030-A | DETECTION OF HYDROGEN PEROXIDE OR PERROXIDASE | BOEHRINGER MANNHEIM GMBH (DE) | 1989-07-04 | — | — | US | claimed |
| WO-2024144717-A2 | NOVEL TRIAZINE-DERIVED COMPOUNDS AND THEIR ANTICANCER EFFECTS | ISTANBUL MEDIPOL UNIVERSITESI (TR) | 2024-07-04 | — | — | WO | disclosed |
| CN-114516848-B | Preparation method of polycarbonate high-temperature degradation resistant agent and polycarbonate composition | 万华化学集团股份有限公司 | 2024-02-02 | — | — | CN | disclosed |
| CN-117024372-A | Synthesis method of benzothiazoline | 温州大学新材料与产业技术研究院 | 2023-11-10 | — | — | CN | disclosed |
| EP-3668948-B1 | POLYMERISABLE LIQUID CRYSTAL MATERIAL AND POLYMERISED LIQUID CRYSTAL FILM | MERCK PATENT GMBH (DE) | 2023-10-25 | — | — | EP | disclosed |
| US-20230130269-A1 | LIQUID CRYSTAL COMPOSITION, LIQUID CRYSTAL CURED LAYER, OPTICAL FILM, POLARIZING PLATE, AND IMAGE DISPLAY DEVICE | FUJIFILM CORPORATION (JP) | 2023-04-27 | — | — | US | disclosed |
| WO-2022262671-A1 | MACRO HETEROCYCLIC COMPOUND AND MEDICAL USE THEREOF | 中国医药研究开发中心有限公司 | 2022-12-22 | — | — | WO | disclosed |
| US-11518745-B2 | Heterocyclic compounds for the treatment of neurological and psychological disorders | ALKERMES PHARMA IRELAND LIMITED (IE) | 2022-12-06 | — | — | US | disclosed |
| CN-114516848-A | Preparation method of polycarbonate high-temperature degradation resistant agent and polycarbonate composition | 万华化学集团股份有限公司 | 2022-05-20 | — | — | CN | disclosed |
| EP-3998324-A1 | WAVELENGTH CONVERSION FILM, WAVELENGTH CONVERSION FILM FORMING COMPOSITION, AND CLUSTER-CONTAINING QUANTUM DOT PRODUCTION METHOD | TOKYO OHKA KOGYO CO., LTD. (JP) | 2022-05-18 | — | — | EP | disclosed |
| WO-2009106577-A1 | IMIDAZO [1,2-B] PYRIDAZINE DERIVATIVES FOR THE TREATMENT OF C-MET TYROSINE KINASE MEDIATED DISEASE | NOVARTIS AG (CH) | 2009-09-03 | — | — | WO | disclosed |
| US-7459450-B2 | Neuropeptide receptor modulators | SCHERING CORPORATION (US) | 2008-12-02 | — | — | US | disclosed |
| EP-1564259-B1 | Azo dye, colored curable composition, color filter and producing method therefor | FUJIFILM CORP (JP) | 2008-03-12 | — | — | EP | disclosed |
| US-20070281937-A1 | Ion Channel Modulators | SCION PHARMACEUTICALS, INC. | 2007-12-06 | — | — | US | disclosed |
| WO-2005097112-A2 | ION CHANNEL MODULATORS | WYETH (US) | 2005-10-20 | — | — | WO | disclosed |
| US-5204242-A | Coupling component for colorimetric analysis of detection of oxidative coupling reaction; peroxide or peroxidase or aromatic amine detection | BOEHRINGER MANNHEIM GMBH (DE) | 1993-04-20 | — | — | US | disclosed |
| US-4708810-A | LUBRICANT ADDITIVE | CASTROL LIMITED (GB) | 1987-11-24 | — | — | US | disclosed |
| EP-0043292-B1 | PROSTAGLANDINS | NATIONAL RESEARCH DEVELOPMENT CORPORATION (GB) | 1986-01-15 | — | — | EP | disclosed |
| EP-0002938-B1 | NOVEL HETEROCYCLIC CARBOTHIOAMIDES, COMPOSITIONS CONTAINING THEM, THEIR PREPARATION AND USE | ELI LILLY AND COMPANY (US) | 1982-05-12 | — | — | EP | disclosed |
| US-4289766-A | Heterocyclic carbothioamides | ELI LILLY AND COMPANY (US) | 1981-09-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070281937-A1 | Ion Channel Modulators | CACNA1B, CACNA1C, TRPV1 | IDO1 4094/4885MEN1 3147/4885KMT2A 3236/4885 |
| US-11518745-B2 | Heterocyclic compounds for the treatment of neurological and psychological disorders | GABBR1, GABBR2, GABRE | IDO1 762/4885MEN1 1443/4885KMT2A 1652/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.